Entaire CEO Jonathan Rosen Named to Board of Directors of Algaeon, Inc.- Leading Firm Focused on Deriving High Value Nutrients From Algae
ATLANTA, June 26, 2014 /PRNewswire/ -- Entaire Global Companies, Inc. (Entaire) announced today the appointment of Entaire CEO Jonathan D. Rosen to the board of directors of Algaeon, Inc. – a leader in the development of algae derived human nutraceuticals and natural animal/fish feed supplements. Mr. Rosen's addition to the Algaeon board of directors will enable the firm to leverage Rosen's considerable experience within the financial sector to the firm's advantage as they raise Algaeon's profile to an international level in the micronutrient market. Algaeon is seeing strong demand for its products in the human nutrient as well as animal feedstock markets. Additional demand comes from the usage of one of their products as a replacement for the prophylactic use of antibiotics in the animal feed markets.
"We are excited to have Jonathan join the board as we enter a new phase in the growth of the firm," remarked Algaeon Chairman and CEO Paul DeLacey. "Jonathan's experience and strong background in finance, transactions and deal structure provide a unique perspective and insight into many of the challenges and opportunities faced by Algaeon – a perspective that will be critical as we continue expansion of partnerships and strategic alliances as part of our medium to long term growth goals."
Rosen added, "I'm delighted to be joining the Algaeon Board of Directors and build on the solid base already in place. As global demand continues to drive the search for the efficient, natural delivery of micronutrients, Algaeon is well positioned to lead the way. I'm excited to be a part of the organization and look forward to being able to help the Company realize its potential."
About Entaire Global Companies, Inc.
Entaire Global Companies, Inc. a privately-held, diversified financial services holding company, is headquartered in metropolitan Atlanta, GA. Founded in 1997, Entaire is dedicated to providing innovative and unique financial strategies and solutions through its subsidiary companies to a diverse corporate client base. Entaire's affiliations with world-class financial institutions, insurance companies and annuity carriers enable it to offer innovative solutions for businesses, medical practices and individuals—with an advantage in tax efficiency, stability and selectivity over traditional financial vehicles.
About Algaeon, Inc.
Algaeon Inc. is an Indianapolis-based biotech company that has developed a breakthrough patented industrial scale microalgae cultivation technology. Unique high value products are currently being grown for leading companies in the Nutraceutical and Animal Micronutrient markets. For more information about Algaeon visit www.algaeon-inc.com.
Press Contact:
Eric Stein, Entaire Global Companies; (678) 218-1220; [email protected]
SOURCE Entaire Global Companies, Inc.
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article